KRAS and non-small cell lung carcinoma: In a sub-cohort of CodeBreaK 101 (NCT04185883), trametinib in combination with sotorasib was given to 41 patients with previously treated advanced KRAS G12C-mutated solid tumors (18 with NSCLC, 18 with CRC, and 5 with others).